Promoter methylation analysis of DKK2 may be a potential biomarker for early detection of cervical cancer.

Published in: Asian biomedicine : research, reviews and news (2022)

hypermethylation could be used as a triage test for screening, early diagnosis, or risk prediction of cervical cancer.

Keyphrases